Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.8.0.1
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 68,556 $ 52,906
Trading account assets, pledged as collateral 107,906 106,274
Debt securities:    
Held-to-maturity, fair value 119,132 123,299
Loans and leases, measured at fair value 5,989 5,710
Loans held-for-sale, measured at fair value 3,091 2,156
Other assets, measured at fair value 20,575 22,581
Deposits in U.S. offices:    
Interest-bearing, measured at fair value 435 449
Federal funds purchased and securities loaned or sold under agreements to repurchase, measured at fair value 35,116 36,182
Short-term borrowings, measured at fair value 2,284 1,494
Accrued expenses and other liabilities, measured at fair value 20,176 22,840
Accrued expenses and other liabilities, reserve for unfunded lending commitments 782 777
Long-term debt, measured at fair value $ 30,062 $ 31,786
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,931,683 3,837,683
Preferred stock outstanding (in shares) 3,931,683 3,837,683
Common stock par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 10,175,910,851 10,287,302,431
Common stock outstanding (in shares) 10,175,910,851 10,287,302,431
Consolidated VIEs | Long-term debt    
Shareholders’ equity    
Non-recourse debt $ 10,050 $ 9,872
Consolidated VIEs | Other liabilities    
Shareholders’ equity    
Non-recourse debt $ 35 $ 34